Endometrial Cancer

There was a trend of different 5-year RFS among the groups, with the shortest among patients with MLH1-hypermethylated disease at 78.6% compared with 95.5% among patients with other causes of MMRd.

The study researchers reported that endometrial cancers with these somatic mutations have unfavorable pathologic features.

Researchers found that the benefit of adjuvant therapy differed depending on the status of peritoneal cytology in women with endometrial cancer.

Researchers sought to determine if LNG-IUD is effective and whether the addition of weight loss or metformin can further improve response in patients with EAC and EHA.

Does abemaciclib and letrozole effective slow or stop endometrial cancer cell growth?

All patients will receive mirvetuximab soravtansine and pembrolizumab in this study.